BioCentury
ARTICLE | Clinical News

Neoprobe regulatory update

December 18, 1995 8:00 AM UTC

NEOP received notice of allowance for a U.S. patent covering its RIGS/ACT adoptive cellular therapy, which is an adjuvant to RIGS surgery. Using RIGS/ACT, a surgeon removes lymph nodes identified by N...